Literature DB >> 10772664

When is a death from prostate cancer not a death from prostate cancer?

P Albertsen.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10772664     DOI： 10.1093/jnci/92.8.590

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy.

Authors:  Efstathios Kastritis; Marie-Christine Kyrtsonis; Pierre Morel; Maria Gavriatopoulou; Evdoxia Hatjiharissi; Argirios S Symeonidis; Amalia Vassou; Panagiotis Repousis; Sossana Delimpasi; Anastasia Sioni; Evrydiki Michalis; Michail Michael; Elina Vervessou; Michael Voulgarelis; Costantinos Tsatalas; Evangelos Terpos; Meletios A Dimopoulos
Journal:  Haematologica       Date:  2015-08-20       Impact factor: 9.941

2.  Primary radiotherapy vs conservative management for localized prostate cancer--a population-based study.

Authors:  G L Lu-Yao; S Kim; D F Moore; W Shih; Y Lin; R S DiPaola; S Shen; A Zietman; S-L Yao
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-06-23       Impact factor: 5.554

3.  Accuracy of cause of death data routinely recorded in a population-based cancer registry: impact on cause-specific survival and validation using the Geneva Cancer Registry.

Authors:  Robin Schaffar; Elisabetta Rapiti; Bernard Rachet; Laura Woods
Journal:  BMC Cancer       Date:  2013-12-27       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.